Table 1 Descriptive statistics of patient groups
From: Total cardiolipin levels in gastric and colon cancer: evaluating the prognostic potential
Colon cancer | Gastric cancer | |
|---|---|---|
N = 41 | N = 40 | |
Sex | ||
Male | 21 (51%) | 12 (30%) |
Female | 20 (49%) | 28 (70%) |
Age (years) | ||
Mean (SD) | 69 (10) | 67 (12) |
Median [Min, Max] | 72 [34, 81] | 68 [31, 86] |
BMI, kg/m² | ||
Mean (SD) | 27.2 (4.7) | 26.4 (5.8) |
Median [Min, Max] | 27.9 [18.0, 40.5] | 25.9 [18.8, 53.4] |
BMI category | ||
Underweight (< 18.5 kg/m²) | 1 (2.4%) | 0 (0%) |
Normal (18.5–24.9 kg/m²) | 14 (34%) | 18 (45%) |
Overweight (25–30 kg/m²)) | 17 (41%) | 15 (38%) |
Obese (> 30 kg/m²)) | 9 (22%) | 7 (18%) |
Smoking status | ||
Never smoked | 24 (59%) | 16 (40%) |
Current or ex-smoker | 17 (41%) | 24 (60%) |
Stage | ||
I | - | 4 (10%) |
II | - | 12 (30%) |
III | - | 20 (50%) |
IV | - | 2 (5%) |
No Data | - | 2 (5%) |
T Stage | ||
T1 | - | 3 (7.5%) |
T2 | - | 6 (15%) |
T3 | - | 8 (20%) |
T4 | - | 23 (57.5%) |
N Stage | ||
N0 | - | 11 (27.5%) |
N1 | - | 10 (25%) |
N2 | - | 8 (20%) |
N3 | - | 11 (27.5%) |
M Stage | ||
M1 | - | 38 (95%) |
M2 | - | 2 (5%) |